AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
RENO, NEV. -- Ultrasound markers and biochemical findings can accurately predict trisomy 18 risk in fetuses with choroid plexus cysts, eliminating the need for amniocentesis in a large percentage of cases, Dr. Lorraine Dugoff reported.
She based this assertion on the initial results of an ongoing prospective collaborative project being conducted at seven centers in the United States and Canada.
Thus far, data have been collected for 157 fetuses with choroid plexus cysts measuring 3 mm or more in diameter, Dr. Dugoff said in a poster session at the annual meeting of the Society for Maternal-Fetal Medicine. None of the 149 cases with a normal karyotype had both ultrasound and biochemical markers for trisomy 18, and all 6 of the trisomy 18 cases had at least two abnormal ultrasound markers and abnormal biochemistry.
Choroid plexus cysts occur in 0.18%-2.5% of second-trimester fetuses and are associated with aneuploidy, particularly trisomy 18.
The single case of trisomy 21 identified in the study also had a positive ultrasound marker and findings on the triple screen suggestive of an ...
Source: HighBeam Research, Ultrasound, Triple Screen Predict Trisomy 18 Risk.